One study evaluated the expression patterns of TAM populations in CRLM, CRC patients and nonmetastatic HCC, reporting that SPP1+ TAMs were enriched in liver metastases, with levels even higher than those in matched primary CRC tumors, despite their absence in nonmetastatic HCC. Here, SPP1 is linked to hepatocellular carcinoma.